Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Yellow Round 10 mm, Tablet with imprint "IG;280". It contains Topiramate 100 mg; of Topiramate[topiramate];. This belongs to the Cytochrome p450 2c19 inhibitors, cytochrome p450 3a4 inducers, decreased central nervous system disorganized electrical activity pharmacologic class. It is manufactured by Camber Pharmaceuticals, Inc.. For details please contact your physician.
Basic Information
- Imprint
- IG;280
- Color
- Yellow
- Shape
- Round
- Size
- 10 mm
Drug Information
- Strength
- Topiramate 100 mg;
- Dosage Form
- Tablet
- RxCUI
- 199889
Pharmaceutical Classification
Related Medications
Other drugs in the same class: Cytochrome P450 2C19 Inhibitors, Cytochrome P450 3A4 Inducers, Decreased Central Nervous System Disorganized Electrical Activity
- Topamaxtopiramate 100 mg;YELLOW • ROUND
- Topamaxtopiramate 15 mg;WHITE • CAPSULE
- Topamaxtopiramate 200 mg;ORANGE • ROUND
- Topamaxtopiramate 25 mg;YELLOW • ROUND
- Topamaxtopiramate 50 mg;YELLOW • ROUND
- topiramateTOPIRAMATE 100 mg;YELLOW • ROUND
- topiramateTOPIRAMATE 200 mg;BROWN • ROUND
- topiramateTOPIRAMATE 25 mg;WHITE • ROUND
- topiramateTOPIRAMATE 50 mg;YELLOW • ROUND
- TopiramateTOPIRAMATE 100 mg;YELLOW • OVAL
Ingredients
- Active Ingredients
- Topiramate[topiramate];
- Inactive Ingredients
- Lactose monohydrate;cellulose, microcrystalline;starch, corn;sodium starch glycolate type a potato;magnesium stearate;silicon dioxide;hypromellose 2910 (3 mpa.s);hypromellose 2910 (6 mpa.s);polyethylene glycol 400;polysorbate 80;ferric oxide yellow;ferric oxide red;
Additional Information
- Manufacturer
- Camber Pharmaceuticals, Inc.
- Status (Rx/OTC)
- Rx
- Brand Names
- Eprontia, Qsymia, Qudexy, Topamax, Trokendi
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.